BNET Industries
Millipore Corp. (MIL) is in the Health Care Industry
- Revenue
- Dec 31 2007
- $1.5B
- Profit
- Dec 31 2007
- $136.4M
- Market Cap
- Jul 23 2008
- $4.0B
Latest News and Analysis
Hedge Fund Tracking: Blue Ridge Capital (John A. Griffin)
Market Folly submits: (Note: Before reading this update, make sure you check out the preface to the series I'm doing on Hedge Fund 13Fs here.) Alright, so now we're cruising through these hedge funds having already covered Steven Mandel's Lone Pine Capital and Boone Pickens' BP Capital. Next up,...
Millipore Corp. Q1 2008 Earnings Call Transcript
Millipore Corp. Q1 2008 Earnings Call Transcript
Millipore Corp. Q4 2007 Earnings Call Transcript
Millipore Corp. Q4 2007 Earnings Call Transcript
Millipore Corporation, Inc. Q3 2007 Earnings Call Transcript
Millipore Corporation, Inc. Q3 2007 Earnings Call Transcript
Protein Concentration and Diafiltration by Tangential Flow Filtration
Membrane-based Tangential Flow Filtration TFF unit operations are used for clarifying, concentrating, and purifying proteins. This technical brief is a practical introduction to protein processing using tangential flow filtration. It is intended to help scientists and engineers achieve their protein processing objectives by discussing how the choice of key components...
Additional Resources
Millipore Announces Date and Time of Second Quarter Earnings Release and Webcast
BILLERICA, Mass. -- Millipore Corporation (NYSE:MIL), a Life Science leader providing technologies, tools and services for bioscience research and biopharmaceutical manufacturing, today announced that it will disclose its second quarter financial results on Thursday, July 31, 2008, after the close of stock market. The Company will webcast a conference call...
Millipore Unveils Expanded Drug Discovery Development Facility in St. Charles, Missouri
Expansion includes new labs, offices and will house 60 new employees BILLERICA, Mass. -- Millipore Corporation, a Life Science leader providing technologies, tools and services for bioscience research and biopharmaceutical manufacturing, today unveiled a major expansion of its St. Charles, Missouri facility - headquarters for its Drug Discovery...
Millipore Corporation Awards Grant to Scientist at Scripps Research Institute of California
Internationally recognized researcher Dr. Jeanne Loring receives $150,000 grant BILLERICA, Mass. -- Millipore Corporation (NYSE: MIL), a Life Science leader providing technologies, tools and services for bioscience research and biopharmaceutical manufacturing, today awarded Dr. Jeanne Loring, Ph.D. a $150,000 grant for her work in stem cell research at...
Millipore Corporation Exhibits at BIO 2008 in San Diego, California, June 17-20, 2008 at Booth # 931 and Booth #5201
CEO Martin Madaus to Make Opening Remarks at BIO Ribbon Cutting Ceremony BILLERICA, Mass. -- Millipore Corporation (NYSE:MIL), a life science leader that provides technologies, tools and services for bioscience research and biopharmaceutical manufacturing, today announced it will be exhibiting at BIO International 2008 in San Diego, Calif....
Millipore Announces New Bioscience Division President
BILLERICA, Mass. -- Millipore Corporation (NYSE:MIL), a life science leader that provides technologies, tools and services for bioscience research and biopharmaceutical manufacturing, today announced that Jon DiVincenzo has been appointed to succeed Dominique Baly as the President of its Bioscience Division. Mr. DiVincenzo, currently the Vice President, Global Sales and...
Company Profile for Stibo Catalog, Inc
Stibo Catalog helps companies aggregate, manage, and distribute product information efficiently. With approximately 180 employees in the United States, United Kingdom, Germany, Denmark, India, and Singapore, it is part of the Stibo A/S group of companies. Stibo Catalog's customers include Premier Farnell, Siemens, RS Components, Millipore, Conrad Electronic, Patterson Companies,...
Millipore Announces Major, Multi-Year Environmental Effort
Global Sustainability Initiative will reduce corporation's carbon footprint BILLERICA, Mass. -- Millipore Corporation (NYSE: MIL), a Life Science leader providing technologies, tools and services for bioscience research and biopharmaceutical manufacturing, today announced a global Sustainability Initiative - an ambitious effort aimed at reducing the company's environmental impacts and...
Millipore to Webcast Annual Shareholder Meeting
BILLERICA, Mass. -- Millipore Corporation (NYSE: MIL), a Life Science leader providing technologies, tools and services for bioscience research and biopharmaceutical manufacturing, today announced that it will webcast its Annual Shareholders meeting on Thursday, May 8, 2008, at 10:00 a.m. Eastern Time. The event will be held at Millipore Corporation...
Millipore to Present at Upcoming Investor Conferences
BILLERICA, Mass. -- Millipore Corporation (NYSE: MIL), a Life Science leader providing technologies, tools and services for bioscience research and biopharmaceutical manufacturing, today announced that it will webcast its presentation at the following upcoming investor conferences: [TABLE OMITTED] The presentation can be accessed through Millipore's homepage, http://www.millipore.com. ...
Millipore Reports First Quarter 2008 Financial Results
BILLERICA, Mass. -- Millipore Corporation (NYSE:MIL), a life science leader that provides technologies, tools and services for bioscience research and biopharmaceutical manufacturing, today reported financial results for its first quarter ended March 29, 2008. Revenues for the first quarter grew 7 percent, totaling $396.2 million. Excluding an 8...
Millipore Announces Date and Time of First Quarter Earnings Release and Webcast
BILLERICA, Mass. -- Millipore Corporation (NYSE:MIL), a Life Science leader providing technologies, tools and services for bioscience research and biopharmaceutical manufacturing, today announced that it will disclose its first quarter financial results on Wednesday, April 30, 2008, after the close of stock market. The Company will webcast a conference call...
Millipore Announces Availability of Proxy Materials for its 2008 Annual Shareholder Meeting
BILLERICA, Mass. -- Millipore Corporation (NYSE: MIL), a life science leader providing technologies, tools and services for the bioscience research and biopharmaceutical manufacturing industry, today announced that the Company's proxy materials for its 2008 Annual Shareholder Meeting are now available on its website. The Securities and Exchange Commission's...
Millipore Corp. Review in Progress.
M2 PRESSWIRE-25 March 2008-MB Alerts: Millipore Corp. Review in ProgressC1994-2008 M2 COMMUNICATIONS LTD RDATE:25032008 MaybachFinancial.com is one of the fastest growing independent and unbiased research firms in the world. Investors wanting to know the truth about investing and how...
Millipore to Webcast Presentation at Bank of America 2008 Small and Mid Cap Conference
BILLERICA, Mass. -- Millipore Corporation (NYSE: MIL), a life science leader providing technologies, tools and services for the bioscience research and biopharmaceutical manufacturing industry, today announced that it will webcast its presentation at the Bank of America 2008 Small and Mid Cap conference on Thursday March 27, 2008 at 8:50...
Market Review on Millipore Corp.
M2 PRESSWIRE-24 March 2008-The Street Corner: Market Review on Millipore Corp.C1994-2008 M2 COMMUNICATIONS LTD RDATE:24032008 Streetinvesting.com has now resumed our progressive review of Millipore Corp. (NYSE:MIL) as it opened up $0.07 on below average volume early trading Monday, March...
- Next »
- page 1 of 41
- « Previous
Sort byClose
View Related Content by Tag Close
- Incorporated: 1954
- CEO: Dr. Martin D. Madaus Ph.D.
Millipore provides technologies, tools and services for the discovery, development and production of therapeutic drugs, vaccines and detection tools and other devices. Co.'s products and services are based various enabling technologies, such as filtration, chromatography, cell culture supplements, antibodies and cell lines. Co.'s Bioscience segment provides productsproducts and technologies for life science research. Co.'s Bioprocess Division provides tools and services for the commercial production of bioengineered and pharmaceutical substances, including biologics, vaccines and other biotherapeutic products.
Key Competitors
Millipore Corp. Company Info
Board of Directors
Dr. Martin D. Madaus Ph.D.
Chairman
Dr. Edward M. Scolnick M.D.
Mr. Melvin D. Booth
Ms. Maureen A. Hendricks
Mr. Rolf A. Classon
Mr. Mark Hoffman
Mr. John F. Reno
Ms. Karen E. Welke
Dr. Daniel Bellus Ph.D.
Dr. Robert C. Bishop Ph.D.
Contact Information
290 Concord Road
Billerica, MA
978 715-4321
